Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
Investors weigh fresh details from a Jefferies consumer survey on eVOTLs today, June 15, 2026.
(Oil & Gas 360) – The Fracking Revolution Working Here & Freedom Growing Over There Have UP The Direction We Head With […]
Over the past six months, Meta’s stock price fell to $569.25. Shareholders have lost 12.1% of their capital, which is disappointing considering the S&P 500 has climbed by 8.4%. This might have investors contemplating their next move.
Luxfer has had an impressive run over the past six months as its shares have beaten the S&P 500 by 23.2%. The stock now trades at $18.07, marking a 31.6% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
(Updates with index/price moves, macroeconomic data, and political/company news from the first parag
Over the past six months, Prudential’s shares (currently trading at $108.28) have posted a disappointing 7.9% loss, well below the S&P 500’s 8.4% gain. This might have investors contemplating their next move.
Over the past six months, RLI’s stock price fell to $54.37. Shareholders have lost 16.4% of their capital, which is disappointing considering the S&P 500 has climbed by 8.4%. This may have investors wondering how to approach the situation.
Major digital assets rose Monday, with Bitcoin (BTC-USD) topping $66,000. The CoinDesk Market Ind
SpaceX Rockets Past Palantir in Stunning Post-IPO Valuation Race
The Nasdaq had its best day since March after Wall Street used the U.S.-Iran peace deal as just another excuse to pile into technology stocks. The Dow rose 469 points, or 0.9%. Market breadth was actually mediocre, but everything from Big Tech to software and chips were on the rise, along with other risk assets like crypto firms.
Warby Parker has been treading water for the past six months, recording a small loss of 1.5% while holding steady at $26.43. The stock also fell short of the S&P 500’s 8.4% gain during that period.
Cigna trades at $298.08 and has moved in lockstep with the market. Its shares have returned 7.6% over the last six months while the S&P 500 has gained 8.4%.
(Updates with index/price moves and political news from the first paragraph.) US equity indexes s
Morgan Stanley sees under-owned cyclicals gaining if rates, oil and dollar pressures ease.
Financial institutions play a critical role, offering everything from consumer banking to wealth management and specialized financial solutions. But uncertainty about fiscal and monetary policy has tempered enthusiasm, and over the past six months, the industry has pulled back by 1.9%. This drop is a far cry from the S&P 500’s 8.4% ascent.
Compare diversification, cost, and sector exposure as these two small-cap value ETFs take different approaches to long-term growth.
Stocks surged Monday on news of a U.S.-Iran ceasefire deal. SpaceX added another $239 billion in market cap for good measure.
Stocks Soar on U.S.-Iran Breakthrough and Falling Oil Prices
(Updates with index/price moves, macroeconomic data, and political/company news from the first parag
Compare portfolio concentration, cost, and sector exposure as two top tech ETFs take different approaches to capturing industry gains.
Pfizer's business may be in better shape than investors think.
OUT trades below valuation benchmarks and targets mid-teens 2026 AFFO growth, but high leverage, capex needs and ad-cycle exposure temper upside.
Even though U.S. stocks keep hitting new all-time highs, the broader macro picture suggests that a bit of a defensive tilt is warranted.
Essentially, Goldman Sachs is telling AI stock investors to look past the flashy headline profits and focus on the bills that are coming due. For the better part of the past few years, investors treated the AI spending boom as a clear win for Big Tech. Nvidia’s chips continued to sell like ...